•  
  •  
  •  
  •  

2025-10-02 04:56:44

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  GlaxoSmithKlinePharmaceuticals

Stock Report

  • GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers
  • GlaxoSmithKline Pharmaceuticals Ltd consolidated Q1FY25 PAT at Rs. 182.33 crores
  • GlaxoSmithKline Pharmaceuticals Ltd appoints GoApptiv Pvt Ltd as super stockist
  • GlaxoSmithKline Pharmaceuticals Ltd announces its financial results for the third quarter ended 31st December 2023
  • GlaxoSmithKline Pharmaceuticals Ltd completes VRS in field sales and HO
  • GlaxoSmithKline Pharmaceuticals Ltd Q1 FY24 consolidated PAT slips marginally QoQ to Rs. 132.25 crores
  • GlaxoSmithKline Pharmaceuticals Limited recommends dividend of Rs. 32
  • GlaxoSmithKline Pharmaceuticals Ltd consolidated Q4 FY2023 PAT declines to Rs. 133.43 crores
  • GlaxoSmithKline Pharmaceuticals Ltd Q3FY23 consolidated net profit at Rs. 164.56 crores
  • GlaxoSmithKline Pharmaceuticals Ltd Q1FY23 consolidated PAT at Rs. 119.28 crores
  • GlaxoSmithKline Pharmaceuticals Ltd recommends dividend of Rs. 90
  • GlaxoSmithKline Pharmaceuticals Ltd Q4FY22 consolidated profit at Rs. 1219.05 crores
  • GlaxoSmithKline Pharmaceuticals delivers strong financials led by Pharma growth
  • GlaxoSmithKline Pharmaceuticals Ltd completes sale of facility located at Vemgal, Karnataka
  • GlaxoSmithKline Pharmaceuticals Ltd posts consolidated PAT of Rs. 204.24 crore in Q2FY22

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024